Vankerckhoven A

ORCID: 0000-0001-6289-444X · 2 papers in corpus
2024
British journal of cancer ·doi:10.1038/s41416-024-02578-x

BackgroundSeveral diagnostic prediction models to help clinicians discriminate between benign and malignant adnexal masses are available. This study is a head-to-head comparison of the performance of the Assessment of Different NEoplasias i…

2021
Cancers ·doi:10.3390/cancers13235899

In monotherapy, immunotherapy has a poor success rate in ovarian cancer. Upgrading to a successful combinatorial immunotherapy treatment implies knowledge of the immune changes that are induced by chemotherapy and surgery.MethodologyPatient…